Bank of New York Mellon Corp grew its stake in shares of Imperva Inc (NYSE:IMPV) by 8.5% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 136,025 shares of the software maker’s stock after acquiring an additional 10,627 shares during the period. Bank of New York Mellon Corp owned 0.40% of Imperva worth $6,509,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Ameritas Investment Partners Inc. purchased a new stake in shares of Imperva during the first quarter worth $102,000. KCG Holdings Inc. acquired a new stake in Imperva during the first quarter valued at $201,000. US Bancorp DE boosted its position in Imperva by 142.3% during the first quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock valued at $221,000 after purchasing an additional 3,163 shares during the last quarter. Jane Street Group LLC purchased a new position in Imperva in the first quarter valued at about $224,000. Finally, Trexquant Investment LP purchased a new position in Imperva in the first quarter valued at about $242,000. Institutional investors and hedge funds own 92.72% of the company’s stock.

Several equities research analysts have recently issued reports on IMPV shares. ValuEngine lowered Imperva from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Monness Crespi & Hardt raised their price objective on shares of Imperva from $55.00 to $57.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Evercore ISI set a $56.00 target price on shares of Imperva and gave the company a “buy” rating in a research note on Friday, July 28th. Stephens reiterated an “overweight” rating and issued a $61.00 target price (up from $53.00) on shares of Imperva in a research note on Thursday, July 13th. Finally, Susquehanna Bancshares Inc assumed coverage on shares of Imperva in a research report on Wednesday, June 7th. They issued a “positive” rating and a $60.00 target price for the company. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $52.78.

COPYRIGHT VIOLATION NOTICE: This news story was first reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another site, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this news story can be viewed at

Imperva Inc (IMPV) opened at 43.40 on Monday. The stock’s 50 day moving average is $44.17 and its 200-day moving average is $45.59. The firm’s market cap is $1.47 billion. Imperva Inc has a 12 month low of $34.40 and a 12 month high of $57.24.

Imperva (NYSE:IMPV) last released its quarterly earnings data on Thursday, July 27th. The software maker reported ($0.10) EPS for the quarter, missing the Zacks’ consensus estimate of $0.05 by ($0.15). The company had revenue of $74.44 million for the quarter, compared to the consensus estimate of $74.30 million. Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The company’s revenue for the quarter was up 28.6% compared to the same quarter last year. During the same period last year, the firm earned ($0.23) earnings per share. On average, analysts anticipate that Imperva Inc will post $0.81 earnings per share for the current fiscal year.

In related news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $43.59, for a total value of $4,341,476.82. Following the transaction, the director now owns 99,598 shares in the company, valued at approximately $4,341,476.82. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 2.20% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Want to see what other hedge funds are holding IMPV? Visit to get the latest 13F filings and insider trades for Imperva Inc (NYSE:IMPV).

Institutional Ownership by Quarter for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.